MED Trademark

Trademark Overview

On Thursday, May 19, 2005, a trademark application was filed for MED with the United States Patent and Trademark Office. The USPTO has given the MED trademark a serial number of 78633499. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, May 26, 2017. This trademark is owned by Rx Management, Inc.. The MED trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Online pharmaceutical advice in the nature of providing physicians with information for their patients on polypharmacy or high-risk medications which could result in adverse reactions, toxicity, contraindications and drug interactions, as well as improve patient compliance
med

General Information

Serial Number78633499
Word MarkMED
Filing DateThursday, May 19, 2005
Status800 - REGISTERED AND RENEWED
Status DateFriday, May 26, 2017
Registration Number3223985
Registration DateTuesday, April 3, 2007
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 10, 2006

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Pseudo MarkMEDICATION
Goods and ServicesOnline pharmaceutical advice in the nature of providing physicians with information for their patients on polypharmacy or high-risk medications which could result in adverse reactions, toxicity, contraindications and drug interactions, as well as improve patient compliance

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 27, 2005
Primary Code044
First Use Anywhere DateFriday, December 1, 2000
First Use In Commerce DateThursday, February 1, 2001

Trademark Owner History

Party NameRx Management, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15235
US
Party NameRx Management, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreensburg, PA 15601
US
Party NameRx Management, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreensburg, PA 15601
US

Trademark Events

Event DateEvent Description
Friday, May 27, 2005NEW APPLICATION ENTERED
Tuesday, December 13, 2005ASSIGNED TO EXAMINER
Wednesday, December 14, 2005NON-FINAL ACTION WRITTEN
Wednesday, December 14, 2005NON-FINAL ACTION E-MAILED
Friday, February 10, 2006ASSIGNED TO EXAMINER
Monday, June 12, 2006PAPER RECEIVED
Monday, June 12, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 22, 2006AMENDMENT FROM APPLICANT ENTERED
Saturday, July 22, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 28, 2006ASSIGNED TO LIE
Wednesday, August 16, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 20, 2006NOTICE OF PUBLICATION
Tuesday, October 10, 2006PUBLISHED FOR OPPOSITION
Thursday, November 9, 2006EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, February 23, 2007EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, April 3, 2007REGISTERED-PRINCIPAL REGISTER
Thursday, March 14, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 14, 2013TEAS SECTION 8 & 15 RECEIVED
Monday, April 1, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 1, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, April 1, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, April 3, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, April 1, 2017TEAS SECTION 8 & 9 RECEIVED
Saturday, April 29, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 26, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 26, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, May 26, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, May 26, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, April 3, 2026COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

toxicity contraindications reactions adverse result drug interactions compliance patient improve